Specialist route
Li Benshang
Chief Physician; Doctoral Supervisor
Innovation Diagnosis and Treatment Center, Ward 1 · Shanghai Children's Medical Center International Department
The official SCMC page presents Li Benshang as a senior specialist focused on pediatric CAR-T and related cell therapies for relapsed or refractory leukemia, lymphoma, and solid tumors.
Use this page to decide whether the specialist direction fits the case, then confirm live appointment availability through the hospital channel.
Expert titles, clinic schedules, and registration availability change quickly. Please treat this page as direction-setting and verify live slots with the official hospital system.
CAR-T therapy for relapsed or refractory leukemia · Cell therapy for lymphoma · Cell therapy for pediatric solid tumors · Translational pediatric hematology-oncology
Thursday morning (specialist clinic, Zhangjiang) · Thursday afternoon (VIP clinic, Zhangjiang)
Diagnosis, imaging, surgery notes, lab reports, and treatment history should be organized before booking.
Decide before booking
Start with the disease pattern, age stage, and treatment question. OriEast can turn the records into a concise medical brief before appointment planning.
Innovation Diagnosis and Treatment Center, Ward 1
Shanghai Children's Medical Center International Department
Profile checked: 2026-04-08
Case fit
Start with the disease pattern, age stage, and treatment question. OriEast can turn the records into a concise medical brief before appointment planning.
Potentially relevant for international families seeking advanced cell therapy or CAR-T options for relapsed or refractory pediatric blood cancers or tumors. The reviewed page suggests strong translational expertise but does not explicitly outline foreign-language support or international patient workflows.
Appointment route
For time-sensitive specialists, the practical path is often official expert clinic, specialty clinic, or the same department team when the top slot is unavailable.
- •Thursday morning (specialist clinic, Zhangjiang)
- •Thursday afternoon (VIP clinic, Zhangjiang)
Expert titles, clinic schedules, and registration availability change quickly. Please treat this page as direction-setting and verify live slots with the official hospital system.
Records to prepare
Complete records make the first consultation more efficient, especially for pediatric surgical and specialty cases.
- ✓Recent outpatient or discharge summaries with confirmed and suspected diagnoses
- ✓Imaging reports and source files, such as ultrasound, CT, MRI, endoscopy, or echocardiography when relevant
- ✓Surgery, pathology, genetic, or specialist consultation reports if the child has already been treated
- ✓Medication, growth, feeding, rehabilitation, and symptom timeline notes
- ✓A short question list covering the decision you want the specialist to answer
Biography
According to the official page, Li Benshang is a chief physician and doctoral supervisor in SCMC's Innovation Diagnosis and Treatment Center, Ward 1, and also directs the Cell Preparation Center. The page states that he was among the early domestic pioneers in basic and clinical cell-therapy research for relapsed or refractory pediatric acute leukemia, lymphoma, and solid tumors, and that he has participated in more than 1,000 related clinical cases. It also lists multiple academic leadership roles and overseas study or exchange at St. Jude Children's Research Hospital and the University of Hamburg.
Expertise map
We separate the public profile into disease areas, clinical work, procedures, and academic depth so the page is useful for real appointment decisions.
Specialties
- Pediatric CAR-T cell immunotherapy
- Relapsed or refractory acute leukemia
- Lymphoma
- Pediatric solid tumors
- Cell therapy exploration for autoimmune disease
Practice Areas
- Pediatric hematology-oncology
- Cell therapy
- Immunotherapy
- Translational medicine
Conditions Treated
- Relapsed acute leukemia
- Refractory leukemia
- Lymphoma
- Pediatric solid tumors
- Selected autoimmune diseases
Signature Techniques
- Pediatric CAR-T cell therapy
- Cell preparation and translational cell-therapy programs
Clinical and academic depth
Research focus, roles, awards, and training background help judge whether the specialist has long-term depth in a narrow problem.
Academic Titles
- •Doctoral Supervisor
- •Director of the Cell Preparation Center
- •Visiting Professor at the Shanghai Institute of Hematology
Leadership Track Record & Contributions
- •Participated in 1,000+ related clinical cases
- •Among early domestic pioneers in pediatric CAR-T and cell therapy research
Research Highlights
- •Among the earlier domestic pioneers in basic and clinical cell-therapy research for relapsed or refractory pediatric leukemia, lymphoma, and solid tumors
- •Completed more than 1,000 clinical cases involving relapsed or refractory pediatric hematologic and oncologic diseases
- •Led or participated in studies on dual-target CD19/CD22 CAR-T therapy for pediatric acute lymphoblastic leukemia and lymphoma
- •Recent projects include minimal residual disease detection using ultra-deep sequencing in pediatric leukemia and translational cell-therapy programs for refractory disease
Academic Roles
- •Visiting Professor at the Shanghai Institute of Hematology
- •Vice Chair of the National Health Commission Pediatric Hematologic Diseases and Other Blood Disorders Committee
- •Committee member of the National Health Commission Pediatric Leukemia Expert Committee and Deputy Head of its Clinical Translation Working Group
- •Deputy Head of the New Technology Development Group of the Chinese Anti-Cancer Association Pediatric Oncology Committee
- •Member of the Chinese Medical Association Pediatrics Precision Medicine Committee
- •Committee member of the National Children's Medical Center Hematology/Oncology Alliance
- •Principal Investigator at the National Health Commission Key Laboratory for Pediatric Hematology and Oncology
Education & Overseas Experience
The reviewed official page specifically notes study or exchange at St. Jude Children's Research Hospital in the United States and the University of Hamburg in Germany. A full formal education chronology is not clearly provided in the excerpt reviewed.
Frequently Asked Questions
Is this expert suitable for a second opinion?
Yes. Li Benshang may be a strong option for second-opinion cases involving Pediatric CAR-T cell immunotherapy, Relapsed or refractory acute leukemia, Lymphoma, especially when families want input from a leading pediatric center in Shanghai.
What kinds of cases is this expert best for?
This expert is generally best suited for cases involving Relapsed acute leukemia, Refractory leukemia, Lymphoma, based on the public SCMC profile and the doctor’s main clinical focus.
Can OriEast help arrange the appointment?
Yes. OriEast can help international families prepare records, confirm booking steps, and coordinate communication with Shanghai Children's Medical Center International Department when arranging care.
What records should patients prepare before booking?
Prepare the latest diagnosis, imaging or pathology reports, treatment summaries, medication list, and any key questions for the specialist. Clear English translations are helpful if available.